基本信息
浏览量:104
职业迁徙
个人简介
Levon heads the Vascular Biology and Translational Research Laboratory within the School of Medical Sciences, UNSW Faculty of Medicine. His research program sits within UNSW Medicine’s Thematic Areas of Cardiovascular and Cancer Biology, and has two major objectives:
To better understand how potentially harmful genes are controlled in vascular cells. This arm investigates signalling and transcriptional mechanisms of growth factor and pro-inflammatory cytokine-dependent gene expression, post-translational mechanisms that modify protein behaviour, isolation and characterization of new genes that are induced or repressed by acute vascular cell injury, and the molecular control of vascular cell migration and proliferation. The group has considerable expertise in preclinical models of cardiovascular disease and cancer
To develop novel vascular therapeutic agents for cardiovascular and inflammatory disease, tumour growth and metastasis. The lab is harnessing the outcomes of its fundamental research by pioneering the development of novel anti-gene, gene-therapeutic and small molecule pharmacological strategies targeting regulatory genes in experimental vascular diseases. This involves in-house laboratory research and strategic national and international collaborations with a range of clinical and preclinical specialists, global contract research organisations, leading industrial medicinal chemists and drug development consultants.
To better understand how potentially harmful genes are controlled in vascular cells. This arm investigates signalling and transcriptional mechanisms of growth factor and pro-inflammatory cytokine-dependent gene expression, post-translational mechanisms that modify protein behaviour, isolation and characterization of new genes that are induced or repressed by acute vascular cell injury, and the molecular control of vascular cell migration and proliferation. The group has considerable expertise in preclinical models of cardiovascular disease and cancer
To develop novel vascular therapeutic agents for cardiovascular and inflammatory disease, tumour growth and metastasis. The lab is harnessing the outcomes of its fundamental research by pioneering the development of novel anti-gene, gene-therapeutic and small molecule pharmacological strategies targeting regulatory genes in experimental vascular diseases. This involves in-house laboratory research and strategic national and international collaborations with a range of clinical and preclinical specialists, global contract research organisations, leading industrial medicinal chemists and drug development consultants.
研究兴趣
论文共 307 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gerald Liew,Tania Tsang, Bridget Marshall, Mercy Saw,Levon Michael Khachigian,Stephen Ong,I-Van Ho,Vincent Wong
Yue Li,Ben Wu,Md Jakir Hossain, Lily Quagliata, Connor O’Meara,Marc R. Wilkins,Susan Corley,Levon M. Khachigian
Journal of translational medicineno. 1 (2023): 467-14
引用1浏览0WOS引用
1
0
JACC: Basic to Translational Scienceno. 2 (2023): 171-173
Bo Wang,Levon M. Khachigian, Luke Esau,Michael J. Birrer,Xiaohang Zhao,M. Iqbal Parker, Denver T. Hendricks
crossref(2023)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 14 (2023)
引用0浏览0WOS引用
0
0
Vascular pharmacology (2023): 107232-107232
引用0浏览0WOS引用
0
0
HEART LUNG AND CIRCULATIONno. 5 (2023): e23-e35
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn